A Landmark Trial of 4,000 Babies Challenges Long Held…

A Landmark Trial of 4,000 Babies Challenges Long Held Fears About Paracetamol and Ibuprofen Acetaminophen and ibuprofen are among the most commonly used medications for fever and pain in babies worldwide, yet earlier observational studies had raised genuine concern that acetaminophen use during infancy might be linked to eczema, asthma, or other conditions later in childhood. A landmark randomised controlled trial, the gold standard of medical evidence, published in The Lancet Child & Adolescent Health, now provides the first direct, rigorous test of this question. The trial: Researchers followed nearly 4,000 babies from birth across New Zealand, part of the PIPPA Tamariki study, the largest clinical trial involving children ever conducted in the country. Babies were randomly assigned to receive either acetaminophen or ibuprofen whenever medication was needed for fever or pain during their first year of life. Parents were regularly asked about eczema, asthma symptoms, and bronchiolitis, and researchers reviewed prescription records and hospital data to confirm outcomes. The results, no meaningful difference between the two medica